{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:16:17Z","timestamp":1784042177832,"version":"3.55.0"},"reference-count":24,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background: To investigate the association between metabolic dysfunction-associated steatotic pancreas disease (MASPD) and insulin resistance (IR).  Methods: This cross-sectional study involved 157 participants diagnosed with MASPD based on ultrasonography criteria. Baseline demographic data were collected, including age, gender, and body mass index. Serum levels of fasting glucose, insulin, lipid profile (including total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol), glycated hemoglobin and insulin were measured using standardized laboratory techniques. Abdominal ultrasonography was performed on all participants using convex transducer (frequency range, 3,5 MHz) by experienced radiologist blinded to the clinical data. The association between MASPD and IR was assessed using logistic regression analysis, adjusting for potential confounders. Statistical significance was set at a P-value &lt;0.05.  Results: The logistic regression analysis was performed to verify whether MASPD was a risk factor for IR. After adjusting for gender and age, the results demonstrate a significant correlation between MASPD and markers of IR. TyG index: OR (95%IC) 5.72 (1.90-16.00), P 0.021, and HOMA -IR: OR (95%IC) 6.20 (2.1-22.00) P 0.037.  Conclusion: This study presents a description of MASPD and its association with IR indices. Our findings demonstrate a significant correlation between MASPD and markers of IR. These results suggest that MASPD may contribute to the development of insulin resistance and further highlight the importance of pancreatic health in metabolic disorders.<\/jats:p>","DOI":"10.1590\/s0004-2803.24612024-070","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T11:09:47Z","timestamp":1734692987000},"source":"Crossref","is-referenced-by-count":4,"title":["ASSOCIATION OF \u201cMETABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC PANCREAS DISEASE\u201d (MASPD) AND INSULIN RESISTANCE"],"prefix":"10.1590","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7714-0330","authenticated-orcid":false,"given":"Lu\u00eds Jesuino de Oliveira","family":"ANDRADE","sequence":"first","affiliation":[{"name":"Universidade Estadual de Santa Cruz,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3447-3143","authenticated-orcid":false,"given":"Gabriela Correia Matos de","family":"OLIVEIRA","sequence":"additional","affiliation":[{"name":"Programa Sa\u00fade da Fam\u00edlia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0506-9210","authenticated-orcid":false,"given":"Alcina Maria Vinhaes","family":"BITTENCOURT","sequence":"additional","affiliation":[{"name":"Universidade Federal da Bahia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8462-1098","authenticated-orcid":false,"given":"Gustavo Magno","family":"BAPTISTA","sequence":"additional","affiliation":[{"name":"Cl\u00ednica M\u00e9dica e de Pneumologia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7702-9154","authenticated-orcid":false,"given":"Catharina Peixoto","family":"SILVA","sequence":"additional","affiliation":[{"name":"Escola Bahiana de Medicina e Sa\u00fade P\u00fablica,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4854-6910","authenticated-orcid":false,"given":"Lu\u00eds Matos de","family":"OLIVEIRA","sequence":"additional","affiliation":[{"name":"Escola Bahiana de Medicina e Sa\u00fade P\u00fablica,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1227188","DOI":"10.3389\/fmed.2023.1227188","article-title":"Fatty infiltration of the pancreas: a systematic concept analysis","volume":"10","author":"Mahyoub MA","year":"2023","journal-title":"Front Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"109860","DOI":"10.1016\/j.diabres.2022.109860","article-title":"Pancreatic fat infiltration, \u03b2-cell function and insulin resistance: A study of the young patients with obesity","volume":"187","author":"Wen Y","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00352.2004","article-title":"Beta-cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced G\u00f6ttingen minipigs","volume":"288","author":"Larsen MO","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2337\/diabetes.47.10.1643","article-title":"Prevalence of insulin resistance in metabolic disorders: the Bruneck Study","volume":"47","author":"Bonora E","year":"1998","journal-title":"Diabetes"},{"key":"ref5","first-page":"34","article-title":"Type 2 diabetes: Does pancreatic fat really matter?","author":"Guglielmi V","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.14309\/ajg.0000000000000262","article-title":"Pancreatic Steatosis: An Emerging Clinical Entity","volume":"114","author":"Ramkissoon R","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s00125-015-3544-5","article-title":"Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans","volume":"58","author":"Begovatz P","year":"2015","journal-title":"Diabetologia"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41574-021-00573-3","article-title":"Metabolic implications of pancreatic fat accumulation","volume":"18","author":"Wagner R","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","author":"Simental-Mend\u00eda LE","year":"2008","journal-title":"Metab Syndr Relat Disord"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews DR","year":"1985","journal-title":"Diabetologia"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1590\/s0004-2803.202000000-27","article-title":"Pancreatic steatosis: a new diagnosis and therapeutic challenge in gastroenterology","volume":"57","author":"Paul J","year":"2020","journal-title":"Arq Gastroenterol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"11492 39","DOI":"10.3389\/fendo.2023.1149239","article-title":"The crucial role and mechanism of insulin resistance in metabolic disease","volume":"14","author":"Zhao X","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.diabres.2011.07.015","article-title":"Insulin resistance index (HOMA-IR) levels in a general adult population: curves percentile by gender and age","volume":"94","author":"Gayoso-Diz P","year":"2011","journal-title":"The EPIRCE study.Diabetes Res Clin Pract"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"102581","DOI":"10.1016\/j.dsx.2022.102581","article-title":"Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride\/glucose index","volume":"16","author":"Tahapary DL","year":"2022","journal-title":"Diabetes Metab Syndr"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1507\/endocrj.EJ19-0445","article-title":"Relation between HOMA-IR and insulin sensitivity index determined by hyperinsulinemic-euglycemic clamp analysis during treatment with a sodium-glucose cotransporter 2 inhibitor","volume":"67","author":"So A","year":"2020","journal-title":"Endocr J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.47391\/JPMA.22-63","article-title":"Triglyceride Glucose (TyG) Index: A surrogate biomarker of insulin resistance","volume":"72","author":"Ramdas Nayak VK","year":"2022","journal-title":"J Pak Med Assoc"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.numecd.2021.10.001","article-title":"Dietary glycemic load and its association with glucose metabolism and lipid profile in young adults","volume":"32","author":"Fernandes AC","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.numecd.2021.11.017","article-title":"Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome","volume":"32","author":"Son DH","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"951689","DOI":"10.3389\/fendo.2022.951689","article-title":"Potential screening indicators for early diagnosis of NAFLD\/MAFLD and liver fibrosis: Triglyceride glucose index-related parameters","volume":"13","author":"Xue Y","year":"2022","journal-title":"Front Endocrinol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/met.2023.0116","article-title":"Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population","volume":"21","author":"Moriyama K","year":"2023","journal-title":"Metab Syndr Relat Disord"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2174\/1871530318666180328111302","article-title":"Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review","volume":"18","author":"Romana BS","year":"2018","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"S516","DOI":"10.1055\/s-2001-15114","article-title":"Triglycerides, fatty acids and insulin resistance--hyperinsulinemia","volume":"109","author":"Kraegen EW","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.2174\/0929867324666170518101334","article-title":"Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis","volume":"26","author":"Vergani L","year":"2019","journal-title":"Curr Med Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"G279","DOI":"10.1152\/ajpgi.00074.2023","article-title":"Relationship of circulating levels of long-chain fatty acids to persistent organ failure in acute pancreatitis","volume":"325","author":"Phillips AE","year":"2023","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["Associa\u00e7\u00e3o de \u201cdoen\u00e7a esteat\u00f3tica pancre\u00e1tica associada \u00e0 disfun\u00e7\u00e3o metab\u00f3lica\u201d (MASPD) e resist\u00eancia \u00e0 insulina"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032024000100213&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T11:09:54Z","timestamp":1734692994000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032024000100213&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":24,"alternative-id":["S0004-28032024000100213"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.24612024-070","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e24070"}}